Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
9
FDA:7
CANADA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease
Phase 2
Completed
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2021-05-10
- Lead Sponsor
- Nephron Pharmaceuticals Corporation
- Target Recruit Count
- 116
- Registration Number
- NCT04780984
- Locations
- 🇺🇸
Clinical Research of Rock Hill, Rock Hill, South Carolina, United States
Safety and Efficacy of T-2345 Compared to Xalatan in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Phase 3
Completed
- Conditions
- Primary Open Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Nephron Pharmaceuticals Corporation
- Target Recruit Count
- 335
- Registration Number
- NCT02059278
News
No news found